• Citer

Double-blind, randomized placebo controlled trial of fulvestrant compared with exemestane after prior nonsteroidal aromatase inhibitor therapy in postmenopausal women with hormone receptor-positive, advanced breast cancer: results from EFECT.

par Chia, Stephen;Gradishar, William J.;Mauriac, L;Bines, Jose;Amant, F.;Federico, Miriam;Fein, Luis;Romieu, Gilles;Buzdar, Aman;Robertson, John F R;Brufsky, Adam;Possinger, Kurt;Rennie, Pamela;Sapunar, Francisco;Lowe, Elizabeth;Piccart-Gebhart, Martine
Référence Journal of clinical oncology, 26, 10, page (1664-1670)
Publication Publié, 2008-04

Article révisé par les pairs

• Détails
• Contenu

Titre:	Double-blind, randomized placebo controlled trial of fulvestrant compared with exemestane after prior nonsteroidal aromatase inhibitor therapy in postmenopausal women with hormone receptor-positive, advanced breast cancer: results from EFECT.
Auteur:	Chia, Stephen; Gradishar, William J.; Mauriac, L; Bines, Jose; Amant, F.; Federico, Miriam; Fein, Luis; Romieu, Gilles; Buzdar, Aman; Robertson, John F R; Brufsky, Adam; Possinger, Kurt; Rennie, Pamela; Sapunar, Francisco; Lowe, Elizabeth; Piccart-Gebhart, Martine
Informations sur la publication:	Journal of clinical oncology, 26, 10, page (1664-1670)
Statut de publication:	Publié, 2008-04
Sujet CREF:	Sciences bio-médicales et agricoles
MeSH keywords:	Androstadienes -- therapeutic use
	Antineoplastic Agents -- therapeutic use
	Aromatase Inhibitors -- therapeutic use
	Breast Neoplasms -- drug therapy
	Breast Neoplasms -- metabolism
	Breast Neoplasms -- mortality
	Double-Blind Method
	Estradiol -- analogs & derivatives
	Estradiol -- therapeutic use
	Female
	Humans
	Kaplan-Meiers Estimate
	Neoplasm Recurrence, Local -- drug therapy
	Placebos
	Postmenopause
	Quality of Life
	Receptors, Estrogen -- metabolism
Note générale:	Clinical Trial, Phase III
	Journal Article
	Multicenter Study
	Randomized Controlled Trial
Langue:	Anglais
Identificateurs:	urn:issn:0732-183X
	info:doi/10.1200/JCO.2007.13.5822
	info:pii/JCO.2007.13.5822
	info:pmid/18316794